Neoss® Group launches NeoTell™ a new device to measure implant stability.

NeoTell empowers dental professionals with an intuitive and user-friendly device that delivers objective results without invasive procedures. With this proven technology, clinicians can make informed treatment decisions swiftly and confidently. NeoTell empowers dental professionals with an intuitive and user-friendly device that delivers objective results without invasive procedures. With this proven technology, clinicians can make informed treatment decisions swiftly and confidently. One of...
Comunicato Precedente

next
Comunicato Successivo

next
Preferisci Informazione.News su Google

NeoTell empowers dental professionals with an intuitive and user-friendly device that delivers objective results without invasive procedures. With this proven technology, clinicians can make informed treatment decisions swiftly and confidently.

One of the key advantages of NeoTell is its affordability, making RFA (Resonance Frequency Analysis) technology accessible to a wide range of dental practitioners. This affordability ensures that more clinicians can leverage the benefits of RFA technology. Patients can also anticipate improved outcomes, as this technology enables more precise assessment and treatment planning, ultimately leading to greater confidence and satisfaction in their dental implant procedures.

To learn more about the NeoTell, please visit https://neoss.com/neotell.

About Neoss®

Neoss® Group launches NeoTell™ a new device to measure implant stability.

Neoss was founded with a vision to enhance dental implant treatments for both clinicians and patients. With our extensive expertise in dental implant procedures, we are committed to develop user-friendly and cost-effective solutions that enhance the efficiency of dental professionals and improve patient outcomes. Our products and solutions are designed, researched, and developed in Gothenburg, Sweden – the birthplace of Osseointegration and the renowned pioneer, Professor Per-Ingvar Brånemark. You can have confidence knowing that our offerings are supported by scientific research and long-term clinical results, providing you and your patients with peace of mind. To find out more visit https://neoss.com

 

Video - https://mma.prnewswire.com/media/2209979/NeoTell_logo_animation_PR.mp4
Photo - https://mma.prnewswire.com/media/2209978/NeoTell_PR.jpg
Logo - https://mma.prnewswire.com/media/1489998/Neoss_Logo.jpg 

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/neoss-group-launches-neotell-a-new-device-to-measure-implant-stability-301926950.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;